Why I Like Consort Medical plc (LON:CSRT)

In this article:

I’ve been keeping an eye on Consort Medical plc (LON:CSRT) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CSRT has a lot to offer. Basically, it is a company with a a great track record of dividend payments as well as a buoyant growth outlook. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Consort Medical here.

Reasonable growth potential average dividend payer

LSE:CSRT Future Profit October 26th 18
LSE:CSRT Future Profit October 26th 18

For those seeking income streams from their portfolio, CSRT is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 1.9%.

LSE:CSRT Historical Dividend Yield October 26th 18
LSE:CSRT Historical Dividend Yield October 26th 18

Next Steps:

For Consort Medical, I’ve put together three relevant factors you should further research:

  1. Historical Performance: What has CSRT’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.

  2. Valuation: What is CSRT worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether CSRT is currently mispriced by the market.

  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CSRT? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Advertisement